Time to dump COVID-19 vaccine stocks?

willrocks · Oct 24, 2021

Moderna Given Sell Rating at Deutsche Bank. The Stock Is Falling.

Moderna was under pressure Friday after Deutsche Bank called the Covid-19 vaccine maker a “concept stock,” giving shares in the biotech a Sell rating and price target 34% below the stock’s previous closing price.

Deutsche Bank’s Emmanuel Papadakis initiated coverage of Moderna (ticker: MRNA) with a Sell rating on the shares and a target price of $225.

Moderna closed at $339.57 on Thursday. The shares were slipping 2% lower in premarket trading Friday.

“Moderna is a concept company that has ridden a wave of disruptive innovation, pandemic serendipity and management vision (plus a little public funding) to become a concept stock,” Papadakis said.

Shares in Moderna have soared around 380% over the last year as the group became one of a few companies to successfully develop a Covid-19 vaccine, which has been widely rolled out across the U.S. and other developed countries.
Click to expand...

https://www.barrons.com/articles/moderna-mrna-stock-sell-rating-51634905777

Log in or Sign up

Time to dump COVID-19 vaccine stocks?

willrocks Well-Known Member Silver Stacker

Share This Page

Log in or Sign up

Time to dump COVID-19 vaccine stocks?

willrocks Well-Known Member Silver Stacker

Share This Page

Useful Searches